Shorter radiotherapy
Men undergoing PCa treatment could be safely given far less radiotherapy, a major trial has found. More here
Men undergoing PCa treatment could be safely given far less radiotherapy, a major trial has found. More here
A revolutionary ‘new era’ drug, Lu-PSMA, acts like a ‘guided missile’ to target cancerous cells and spares healthy tissue, writes Eleanor Hayward, Health Correspondent, in the Times.
New study for Black men A team at UCL London is seeking to understand the unique experiences of Black men with PCa care in the UK. It wants to uncover the reasons behind healthcare inequalities and developing targeted support to improve outcomes. See flyer or this website. And an NHS 10-part series aims to support […]
Active monitoring of PCa has the same high survival rates after 15 years as radiotherapy or surgery, reports the ProtecT trial, led by Bristol and Oxford Universities. Although men on active monitoring were more likely to see it progress or spread than those receiving radiotherapy or surgery, this didn’t reduce their likelihood of survival. The […]
Mediterranean diet ‘helps cancer survival chances’. See here  And reducing belly fat is said to slash your risk of PCa – more here There is a new World Cancer Research Fund helpline available on Tuesdays: 12pm–2pm and Thursdays: 6pm–8pm. Call: 0333 034 1988 or email: helpline@wcrf.org more here
Meetings/speakers Coffee mornings are held from 10am-noon at Penny Brohn centre, Pill, on the first Thursday of each month. Meetings are held at the Macmillan Wellbeing Centre at Southmead Hospital every third Tuesday of the month (2-4pm). But be warned that car parking can be difficult. Here’s an update on speakers for BAWA events 7pm: […]
Member Colin Butcher has written an article to help cancer patients and plans more. Find it here
A ’cancer-killing pill’ that appears to ‘annihilate’ tumours is being tested on humans. More here But an unprecedented analysis of how cancers grow has revealed an “almost infinite” ability of tumours to evolve and survive, say scientists. Nine years work left the research team “surprised” and “in awe” at the formidable force they were up […]
Dr Mark Porter tells why he’s never had a PSA test and how few subjects polarise doctors as much as PSA testing. More here
A new drug combination could revolutionise the treatment of advanced PCa and give sufferers months of extra life. More here And NICE has approved darolutamide in combination with hormone therapy and chemotherapy for men with hormone-sensitive advanced PCa. It’s estimated around 6,000 men could benefit (Jun ’23). More here And researchers have found that targeting a single […]